The human innate immune response to pathogens is not fully effective and mature until well into childhood, as exemplified by various responses to Toll-like receptor (TLR) agonists in newborns compared to adults. To better understand the mechanistic basis for this age-related difference in innate immunity, we compared tumor necrosis factor alpha (TNF-␣) production by monocytes from cord blood (CB) and adult blood (AB) in response to LAM (lipoarabinomannan from Mycobacterium tuberculosis, a TLR2 ligand) and LPS (lipopolysaccharide from Escherichia coli, a TLR4 ligand). LPS or LAM-induced TNF-␣ production was 5 to 18 times higher in AB than in CB monocytes, whereas interleukin-1␣ (IL-1␣) stimulated similar levels of TNF-␣ in both groups, suggesting that decreased responses to LPS or LAM in CB are unlikely to be due to differences in the MyD88-dependent signaling pathway. This impaired signaling was attributable, in part, to lower functional TLR4 expression, especially on CD14 ؉
CD16؉ monocytes, which are the primary cell subset for LPS-induced TNF-␣ production. Importantly, the frequency of CD14 ؉ CD16 ؉ monocytes in CB was 2.5-fold lower than in AB (P < 0.01). CB from Kenyan newborns sensitized to parasite antigens in utero had more CD14 ؉ CD16 ؉ monocytes (P ؍ 0.02) and produced higher levels of TNF-␣ in response to LPS (P ؍ 0.004) than CB from unsensitized Kenyan or North American newborns. Thus, a reduced CD14 ؉ CD16 ؉ activated/differentiated monocyte subset and a correspondingly lower level of functional TLR4 on monocytes contributes to the relatively low TNF-␣ response to LPS observed in immunologically naive newborns compared to the response in adults.